本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tyra Biosciences, Inc.

20.12
+0.39001.98%
盘后:20.290.1700+0.84%19:30 EST
成交量:46.76万
成交额:937.55万
市值:13.83亿
市盈率:-7.60
高:20.44
开:19.62
低:19.48
收:19.73
52周最高:40.65
52周最低:18.25
股本:6,875.59万
流通股本:4,024.97万
量比:0.87
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-2.6458
每股收益(LYR):-2.0125
净资产收益率:-34.89%
总资产收益率:-22.15%
市净率:2.00
市盈率(LYR):-10.00

数据加载中...

2026/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/10

重要事件披露

Form 8-K - Current report
2026/10/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/09/21

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/17

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/14

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/09

重要事件披露

Form 8-K - Current report
2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]